Molecular diagnostics in monogenic and multifactorial forms of Type 2 diabetes
- 1 November 2001
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 1 (4) , 403-412
- https://doi.org/10.1586/14737159.1.4.403
Abstract
Type 2 diabetes represents a major and increasing contributor to morbidity and mortality worldwide. Of the world's population, 10% either have Type 2 diabetes, or will develop it during their lifetime. Realization that inherited factors play a leading role in determining individual susceptibility to this condition provides a framework for improved molecular understanding of disease pathogenesis through susceptibility gene discovery. In particular, identification and characterization of these susceptibility variants should lead to improved targeting of available preventative and therapeutic measures and increasingly 'personalized' therapy. This article surveys present knowledge about the genetic basis of Type 2 diabetes and discusses the current and future role of genetic diagnostics, with an emphasis on lessons learned from study of monogenic forms of the disease.Keywords
This publication has 29 references indexed in Scilit:
- The dysmetabolic syndromeJournal of Internal Medicine, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Guilt by associationNature Genetics, 2000
- Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitusNature Genetics, 2000
- The Future of Genetic Studies of Complex Human DiseasesScience, 1996
- A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2Nature Genetics, 1996
- Positional cloning moves from perditional to traditionalNature Genetics, 1995
- Genetic Dissection of Complex TraitsScience, 1994
- Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.Journal of Clinical Investigation, 1994
- Failure to detect cytomegalovirus DNA in pancreas in type 2 diabetesThe Lancet, 1992